A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation

This multicenter phase II study in renal transplantation compared 3 concentration-controlled ranges of FK778 (manitimus) with mycophenolate mofetil (MMF) both given in combination with tacrolimus and corticosteroids.

Saved in:
Bibliographic Details
Main Authors: Włodarczyk, Zbigniew (Author) , Krämer, Bernhard (Author)
Format: Article (Journal)
Language:English
Published: 26 July 2012
In: BMC nephrology
Year: 2012, Volume: 13
ISSN:1471-2369
DOI:10.1186/1471-2369-13-68
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2369-13-68
Verlag, kostenfrei, Volltext: https://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-13-68
Get full text
Author Notes:Zbigniew Wlodarczyk, Yves Vanrenterghem, Bernhard K. Krämer, Jean-Paul Squifflet and Marek Ostrowski
Description
Summary:This multicenter phase II study in renal transplantation compared 3 concentration-controlled ranges of FK778 (manitimus) with mycophenolate mofetil (MMF) both given in combination with tacrolimus and corticosteroids.
Item Description:Gesehen am 26.05.2020
Physical Description:Online Resource
ISSN:1471-2369
DOI:10.1186/1471-2369-13-68